Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Pakistan Journal of Medical Sciences. 2015; 31 (6): 1349-1354
Dans Anglais | IMEMR | ID: emr-175107

Résumé

Objective: To investigate the effects of normal saline [0.9% NaCl] and 6% Hydroxyethyl Starch 130/0.4[HES] solution on Ischemia/Reperfusion [I/R] injury in patients undergoing knee arthroscopy operations with spinal anesthesia using a tourniquet


Methods: The study comprised 48 ASA I-II patients undergoing knee arthroscopy with spinal anesthesia using a tourniquet. The patients were randomised into two groups and after standard monitoring two venous lines were introduced to obtain blood samples and to give intravenous therapy. In the control group [Group A] [n=21] 0.9% NaCl, 10 ml/kg/hours and in the study group [Group B] [n=19] 6% Hydroxyethyl Starch 130/0.4, 10 ml/kg/hours infusion were administered. Spinal anesthesia was applied with 12.5 mg hyperbaric bupivacaine to all patients. The tourniquet was applied and the operation was started when the sensorial block level reached T10 dermatome. Blood xanthine oxidase [XO] and malondialdehyde [MDA] levels as an indicator of ischemia and reperfusion injury were measured in samples before fluid infusion [t1], before tourniquet application [t2], 1 minute before tourniquet release [t3], and at 5 [t4] and 15 [t5] minutes after tourniquet release


Results: No difference was observed between the two groups in respect of demographic parameters, the highest block level, duration before tourniquet application and tourniquet duration [p>0.05]. The MDA level after tourniquet application and 15 minutes after tourniquet release was lower in Group B [p<0.05]. XO levels were not different [p>0.05]


Conclusion: In this study 6% Hydroxyethyl Starch 130/0.4 solution reduced MDA level which is an indicator of lipid peroxidation. 6% Hydroxyethyl Starch 130/0.4 solution may be beneficial for Ischemia/reperfusion injuries


Sujets)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Administration par voie intraveineuse , Hydroxyéthylamidons/pharmacologie , Chlorure de sodium/pharmacologie , Arthroscopie , Genou , Rachianesthésie , Garrots , Xanthine oxidase/sang , Malonaldéhyde/sang
SÉLECTION CITATIONS
Détails de la recherche